Solid Biosciences (SLDB) Total Liabilities: 2017-2023
Historic Total Liabilities for Solid Biosciences (SLDB) over the last 7 years, with Dec 2023 value amounting to $38.5 million.
- Solid Biosciences' Total Liabilities rose 10.99% to $44.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $44.8 million, marking a year-over-year increase of 10.99%. This contributed to the annual value of $38.5 million for FY2023, which is 20.85% down from last year.
- As of FY2023, Solid Biosciences' Total Liabilities stood at $38.5 million, which was down 20.85% from $48.6 million recorded in FY2022.
- In the past 5 years, Solid Biosciences' Total Liabilities ranged from a high of $48.6 million in FY2022 and a low of $23.4 million during FY2019.
- In the last 3 years, Solid Biosciences' Total Liabilities had a median value of $38.5 million in 2023 and averaged $37.1 million.
- As far as peak fluctuations go, Solid Biosciences' Total Liabilities tumbled by 38.16% in 2021, and later surged by 101.03% in 2022.
- Over the past 5 years, Solid Biosciences' Total Liabilities (Yearly) stood at $23.4 million in 2019, then spiked by 66.86% to $39.1 million in 2020, then tumbled by 38.16% to $24.2 million in 2021, then skyrocketed by 101.03% to $48.6 million in 2022, then dropped by 20.85% to $38.5 million in 2023.